MD

Managobinda Dalai

Active Director Director DIN 09168895
DIN 09168895 First appointment May 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Total affiliations 2 Since May 2021
Shareholding value •••• Premium profile

About Managobinda Dalai

Data last updated:

Managobinda Dalai is a Director at Genom Biotech Private Limited (since 2021) and Additional Director at Clestra Life Sciences Private Limited (since 2021). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹4.40 Cr; the largest is Genom Biotech Private Limited at ₹4.20 Cr (FY 2020).

DIN 09168895
Primary Designation Director
Industry Pharma
First Appointment 10 May 2021
Oldest Company Age 28 yrs
Largest company Genom Biotech Private Limited · ₹4.20 Cr (FY 2020)
Combined revenue ₹4.40 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Genom Biotech Private Limited U24239MH2000PTC123931
Director10 May 20212000₹4.20 Cr (FY 2020)Active
Additional Director25 May 20211998₹19.9 Lakh (FY 2017)Active

Board colleagues of Managobinda Dalai

Directorship timeline

Open interactive timeline →
Clestra Life Sciences Private Limited
Genom Biotech Private Limited
Premium access

Shareholding and investment profile for Managobinda Dalai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Managobinda Dalai

Managobinda Dalai currently holds 2 directorships: Genom Biotech Private Limited (Director, since 10 May 2021, revenue ₹4.20 Cr (FY 2020)); Clestra Life Sciences Private Limited (Additional Director, since 25 May 2021, revenue ₹19.9 Lakh (FY 2017)).

Managobinda Dalai was first appointed on 10 May 2021 as Director at Genom Biotech Private Limited.

The 2 current companies of Managobinda Dalai that report revenue have a combined latest revenue of ₹4.40 Cr: Genom Biotech Private Limited ₹4.20 Cr (FY 2020); Clestra Life Sciences Private Limited ₹19.9 Lakh (FY 2017).

The current boards of Managobinda Dalai's companies include Raunit Rathor (Genom Biotech Private Limited), Singh Binod Kumar Sheila (Genom Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available